The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival
Open accessAbstract
SHIP is an inositol 5' phosphatase that hydrolyzes the PI3'K product PI(3,4,5)P3. We show that SHIP-deficient mice exhibit dramatic chronic hyperplasia of myeloid cells resulting in splenomegaly, lymphadenopathy, and myeloid infiltration of vital organs. Neutrophils and bone marrow-derived mast cells from SHIP-/- mice are less susceptible to programmed cell death induced by various apoptotic stimuli or by growth factor withdrawal. Engagement of IL3-R and GM-CSF-R in these cells leads to increased and prolonged PI3'K-dependent PI(3,4,5)P3 accumulation and PKB activation. These data indicate that SHIP is a negative regulator of growth factor-mediated PKB activation and myeloid cell survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This strategy also avoids the developmental effects that can occur in constitutive knockouts.16,17”
From Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease (2023) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which are both processes that can be mediated by Inpp5d. 6 , 20”
From Loss of Inpp5d has disease‐relevant and sex‐specific effects on glial transcriptomes (2024) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upon binding to PI(3,4,5)P3, the 5’ phosphatase catalytic domain phosphorylates PI(3,4,5)P3 to generate PI(3,4)P2, which can bind to the C2 domain near the C-terminus [92, 107, 108].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [92]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SHIP1 is a phosphatase involved in phosphoinositide signaling.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“PI(3,4,5)P3 can be converted back to PI(4,5)P2 by the protein phosphatase and tensin homology (PTEN) or converted into PI(3,4)P2 by SHIP1, which negatively regulates PI3K/Akt signaling (Fig. 2) [89–92].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,874
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Self-citationPI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,665
Mechanisms and consequences of activation of protein kinase B/Akt
Downward, J. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80149-x · Cited by 1,304
The lipid phosphatase activity of PTEN is critical for its tumor supressor function
Myers, M. P., Pass, I., Batty, I. H., KAAY, J. V. D., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P., & Tonks, N. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13513 · Cited by 1,161
Delcommenne, M., Tan, C., Gray, V., Rue, L., Woodgett, J. R., & Dedhar, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11211 · Cited by 1,102
Rozakis-Adcock, M., McGlade, J. C., Mbamalu, G., Pelicci, G., Daly, R. J., Li, W., Batzer, A., Thomas, S. Μ., Brugge, J. S., Pelicci, P. G., et al. (1992) · Nature · doi:10.1038/360689a0 · Cited by 973
Ono, M., Bolland, S. M., Tempst, P., & Ravetch, J. V. (1996) · Nature · doi:10.1038/383263a0 · Cited by 773
RAFF, M. C. (1998) · Nature · doi:10.1038/24055 · Cited by 690
Cited by
Sorted by citations
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature reviews. Cancer · doi:10.1038/nrc839 · Cited by 6,155
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
Ravetch, J. V., & Bolland, S. M. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.275 · Cited by 1,687
Phosphoinositides: Tiny Lipids With Giant Impact on Cell Regulation
Balla, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00028.2012 · Cited by 1,638
The protein kinase B/Akt signalling pathway in human malignancy
Nicholson, K. M., & Anderson, N. G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00271-6 · Cited by 1,665
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., & Glass, D. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1009 · Cited by 1,583
Synthesis and Function of 3-Phosphorylated Inositol Lipids
Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J., & Waterfield, M. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.535 · Cited by 1,535
Ravetch, J. V., & Lanier, L. L. (2000) · Science · doi:10.1126/science.290.5489.84 · Cited by 1,278
Katso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J. F., & Waterfield, M. D. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.615 · Cited by 1,234
PI3K/Akt and apoptosis: size matters
Franke, T. F., Hornik, C., Segev, L., Shostak, G. A., & Sugimoto, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207115 · Cited by 1,195
PI3K/AKT signaling pathway and cancer: an updated review
Martini, M., Santis, M. C. D., Braccini, L., Gulluni, F., & Hirsch, E. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.912836 · Cited by 1,195
Function of PI3Kγ in Thymocyte Development, T Cell Activation, and Neutrophil Migration
Sasaki, T., Irie-Sasaki, J., Jones, R. G., Oliveira-dos-Santos, A., Stanford, W. L., Bolon, B. N., Wakeham, A. C., Itié, A., Bouchard, D., Kozieradzki, I., et al. (2000) · Science · doi:10.1126/science.287.5455.1040 · Cited by 1,027
Self-citationBrognard, J., Clark, A. S., Ni, Y., & Dennis, P. A. (2001) · PubMed · Cited by 885
The Regulation and Activities of the Multifunctional Serine/Threonine Kinase Akt/PKB
Kandel, E., & Hay, N. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4690 · Cited by 873
Neutrophils and acute lung injury
Abraham, E. H. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000057843.47705.e8 · Cited by 849
TRB3: A tribbles Homolog That Inhibits Akt/PKB Activation by Insulin in Liver
Du, K., Herzig, S., Kulkarni, R. N., & Montminy, M. (2003) · Science · doi:10.1126/science.1079817 · Cited by 842
Inositol phosphatase SHIP1 is a primary target of miR-155
O'Connell, R. M., Chaudhuri, A. A., Rao, D. S., & Baltimore, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902636106 · Cited by 826
Regulation of mast-cell and basophil function and survival by IgE
Kawakami, T., & Galli, S. J. (2002) · Nature reviews. Immunology · doi:10.1038/nri914 · Cited by 632
Negative Regulation of Cytokine Signaling Pathways
Yasukawa, H., Sasaki, A. T., & Yoshimura, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.143 · Cited by 596
Activation of the PI3K/Akt pathway and chemotherapeutic resistance
West, K. A., Castillo, S. S., & Dennis, P. A. (2002) · Drug Resistance Updates · doi:10.1016/s1368-7646(02)00120-6 · Cited by 591
CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling
Irie-Sasaki, J., Sasaki, T., Matsumoto, W., Opavsky, A., Cheng, M., Welstead, G. G., Griffiths, E. K., Krawczyk, C. M., Richardson, C. D., AITKEN, K. J., et al. (2001) · Nature · doi:10.1038/35053086 · Cited by 557
Self-citationA PtdInsP3- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity
Weiner, O. D., Neilsen, P. O., Prestwich, G. D., Kirschner, M. W., Cantley, L. C., & Bourne, H. R. (2002) · Nature Cell Biology · doi:10.1038/ncb811 · Cited by 522
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
Babar, I., Cheng, C. J., Booth, C. J., Liang, X., Weidhaas, J. B., Saltzman, W. M., & Slack, F. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201516109 · Cited by 506
The role of PI3K in immune cells
Koyasu, S. (2003) · Nature Immunology · doi:10.1038/ni0403-313 · Cited by 493
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease
Oudit, G. Y. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.015 · Cited by 467
PTEN function: how normal cells control it and tumour cells lose it
Leslie, N. R., & Downes, C. P. (2004) · Biochemical Journal · doi:10.1042/bj20040825 · Cited by 447
PTEN: The down side of PI 3-kinase signalling
Leslie, N. R., & Downes, C. P. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00234-0 · Cited by 415
Structure, function, and biology of SHIP proteins
Rohrschneider, L. R., Fuller, J. F., Wolf, I., Liu, Y., & Lucas, D. M. (2000) · Genes & Development · doi:10.1101/gad.14.5.505 · Cited by 294
Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1
Nishio, M., Watanabe, K., Sasaki, J., Taya, C., Takasuga, S., Iizuka, R., Balla, T., Yamazaki, M., Watanabe, H., Itoh, R., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1515 · Cited by 288
Self-citationSakamoto, K. M., & Frank, D. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1137 · Cited by 278
Mammalian phosphoinositide kinases and phosphatases
Sasaki, T., Takasuga, S., Sasaki, J., Kofuji, S., Eguchi, S., Yamazaki, M., & Suzuki, A. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.06.001 · Cited by 283
Self-citationRegulation of Akt Signaling by Sirtuins
Pillai, V. B., Sundaresan, N. R., & Gupta, M. P. (2014) · Circulation Research · doi:10.1161/circresaha.113.300536 · Cited by 262
Akt Induces Osteoclast Differentiation through Regulating the GSK3β/NFATc1 Signaling Cascade
Moon, J. B., Kim, J. H., Kim, K., Youn, B. U., Ko, A., Lee, S. Y., & Kim, N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101254 · Cited by 259
Takeshita, S., Namba, N., Zhao, J. J., Jiang, Y., Genant, H. K., Silva, M. J., Brodt, M. D., Helgason, C. D., Kalesnikoff, J., Rauh, M. J., et al. (2002) · Nature Medicine · doi:10.1038/nm752 · Cited by 250
Toll-like receptor signal transduction
Krishnan, J., Selvarajoo, K., Tsuchiya, M., Lee, G., & Choi, S. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.47 · Cited by 252
Neutrophil β2 integrins: moderators of life or death decisions
Mayadas, T. N., & Culleré, X. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.05.002 · Cited by 247
Negative Regulation of Immunoreceptor Signaling
Veillette, A., Latour, S., & Davidson, D. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.130710 · Cited by 242
Critical Roles of Pten in B Cell Homeostasis and Immunoglobulin Class Switch Recombination
Suzuki, A., Kaisho, T., Ohishi, M., Tsukio-Yamaguchi, M., Tsubata, T., Koni, P. A., Sasaki, T., Mak, T. W., & Nakano, T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021101 · Cited by 235
Self-citationSHIP Recruitment Attenuates FcγRIIB-Induced B Cell Apoptosis
Pearse, R. N., Kawabe, T., Bolland, S. M., Guinamard, R., Kurosaki, T., & Ravetch, J. V. (1999) · Immunity · doi:10.1016/s1074-7613(00)80074-6 · Cited by 218
Thompson, J. E., & Thompson, C. B. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.103 · Cited by 208
ITAMs versus ITIMs: striking a balance during cell regulation
Billadeau, D. D., & Leibson, P. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14843 · Cited by 197
ITAMs versus ITIMs: striking a balance during cell regulation
Billadeau, D. D., & Leibson, P. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214843 · Cited by 192
Dok-3, a Novel Adapter Molecule Involved in the Negative Regulation of Immunoreceptor Signaling
Lemay, S., Davidson, D., Latour, S., & Veillette, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2743-2754.2000 · Cited by 191
Taylor, V., Wong, M. P., Brandts, C., Reilly, L., Dean, N. M., Cowsert, L. M., Moodie, S. A., & Stokoe, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6860-6871.2000 · Cited by 182
Yamanashi, Y., Tamura, T., Kanamori, T., Yamane, H., Nariuchi, H., Yamamoto, T. S., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.1.11 · Cited by 181
Influence of SHIP on the NK Repertoire and Allogeneic Bone Marrow Transplantation
Wang, J.-W., Howson, J. M., Ghansah, T., Desponts, C., Ninos, J. M., May, S. L., Nguyen, K. H. T., Toyama-Sorimachi, N., & Kerr, W. G. (2002) · Science · doi:10.1126/science.1068438 · Cited by 178
Dutton, A., Reynolds, G. M., Dawson, W. O., Young, L. S., & Murray, P. G. (2005) · The Journal of Pathology · doi:10.1002/path.1725 · Cited by 178
Wada, T., Sasaoka, T., Funaki, M., Hori, H., Murakami, S., Ishiki, M., Haruta, T., Asano, T., Ogawa, W., Ishihara, H., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1633-1646.2001 · Cited by 177
Excitable Signal Transduction Networks in Directed Cell Migration
Devreotes, P. N., Bhattacharya, S., Edwards, M., Iglesias, P. A., Lampert, T. J., & Miao, Y. (2017) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100616-060739 · Cited by 170
Scheid, M. P., Huber, M., Damen, J. E., Hughes, M. R., Kang, V. H., Neilsen, P. O., Prestwich, G. D., Krystal, G., & Duronio, V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106755200 · Cited by 166
Harder, K. W., Parsons, L. M., Armes, J. E., Evans, N., Kountouri, N., Clark, R., Quilici, C., Grail, D., HODGSON, G. S., Dunn, A. R., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00208-4 · Cited by 165
The roles of Dok family adapters in immunoreceptor signaling
Mashima, R., Hishida, Y., Tezuka, T., & Yamanashi, Y. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00844.x · Cited by 154
T-cell signalling and autoimmunity: molecular mechanisms of disease
Ohashi, P. S. (2002) · Nature reviews. Immunology · doi:10.1038/nri822 · Cited by 148
Akt as a therapeutic target in cancer
Steelman, L. S., Stadelman, K. M., Chappell, W. H., Horn, S., Bäsecke, J., Cervello, M., Nicoletti, F., Libra, M., Stivala, F., Martelli, A. M., et al. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.9.1139 · Cited by 145
Brooks, R., Fuhler, G. M., Iyer, S., Smith, M. J., Park, M.-Y., Paraiso, K. H. T., Engelman, R. W., & Kerr, W. G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902844 · Cited by 140
Essential Role of AKT-1/Protein Kinase Bα in PTEN-Controlled Tumorigenesis
Stiles, B. L., Gilman, V., Khanzenzon, N., Lesche, R., Li, A., Qiao, R., Liu, X. Z., & Wu, H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3842-3851.2002 · Cited by 137
Duan, M., Li, W. C., Vlahos, R., Maxwell, M. J., Anderson, G. P., & Hibbs, M. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200660 · Cited by 133
Cuadrado, E., van den Biggelaar, M., de Kivit, S., Chen, Y.-Y., Slot, M., Doubal, I., Meijer, A., van Lier, R. A. W., Borst, J., & Amsen, D. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.008 · Cited by 132
AKT Signaling in Physiology and Disease
Vasudevan, K. M., & Garraway, L. A. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_66 · Cited by 135
Dong, F., & Larner, A. C. (2000) · Blood · doi:10.1182/blood.v95.5.1656.005k29_1656_1662 · Cited by 131
Lipid phosphatases in the immune system
Krystal, G. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0222 · Cited by 131
Becker, E., Huynh‐Do, U., Holland, S. J., Pawson, T. J., Daniel, T. O., & Skolnik, E. Y. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1537-1545.2000 · Cited by 132
Regulation of granulopoiesis by transcription factors and cytokine signals
Ward, A. C., Loeb, D., Soede-Bobok, A. A., Touw, I., & Friedman, A. (2000) · Leukemia · doi:10.1038/sj.leu.2401808 · Cited by 134
Whitlock, B. B., Gardai, S. J., Fadok, V. A., Bratton, D. L., & Henson, P. M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.6.1305 · Cited by 131
Ivo, P. T. (2006) · Frontiers in bioscience · doi:10.2741/2103 · Cited by 130
Kalesnikoff, J., Baur, N., Leitges, M., Hughes, M. R., Damen, J. E., Huber, M., & Krystal, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4737 · Cited by 130
Hypoxia-induced p53 modulates both apoptosis and radiosensitivity via AKT
Leszczyńska, K. B., Foskolou, I. P., Abraham, A., Anbalagan, S., Tellier, C., Haider, S. A., Span, P. N., O’Neill, E. E., Buffa, F. M., & Hammond, E. M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80402 · Cited by 135
PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis
Besson, A., Robbins, S. M., & Yong, V. W. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00542.x · Cited by 129
KIMBER, W. A., Trinkle‐Mulcahy, L., Cheung, P., Deák, M., MARSDEN, L. J., Kieloch, A., Watt, S. A., Javier, R. T., Alex, G. R. A. Y., Downes, C. P., et al. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610525 · Cited by 129
Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia
Luo, J.-M., Yoshida, H., Komura, S., Ohishi, N., Pan, L., Shigeno, K., Hanamura, I., Miura, K., Iida, S., Ueda, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402725 · Cited by 127
Dong, S., Corre, B., Foulon, E., Dufour, E., Veillette, A., Acuto, O., & Michel, F. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060650 · Cited by 126
Prasad, N. K., Topping, R. S., & Decker, S. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1416-1428.2001 · Cited by 126
Freeburn, R. W., Wright, K. L., Burgess, S., Astoul, E., Cantrell, D. A., & Ward, S. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5441 · Cited by 121
Pauls, S. D., & Marshall, A. J. (2017) · European Journal of Immunology · doi:10.1002/eji.201646795 · Cited by 118
Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions
Subramanian, K. K., Jia, Y., Zhu, D., Simms, B. T., Jo, H., Hattori, H., You, J., Mizgerd, J. P., & Luo, H. R. (2007) · Blood · doi:10.1182/blood-2006-10-055319 · Cited by 118
Phosphoinositide phosphatases in cell biology and disease
Yang, L., & Bankaitis, V. A. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.12.001 · Cited by 128
Expansion of Myeloid Suppressor Cells in SHIP-Deficient Mice Represses Allogeneic T Cell Responses
Ghansah, T., Paraiso, K. H. T., Highfill, S. L., Desponts, C., May, S. L., McIntosh, J. K., Wang, J.-W., Ninos, J. M., Brayer, J. B., Cheng, F., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7324 · Cited by 104
Li (2009) · International Journal of Oncology · doi:10.3892/ijo_00000306 · Cited by 103
The role of SHIP in cytokine-induced signaling
Kalesnikoff, J., Sly, L. M., Hughes, M. R., Büchse, T., Rauh, M. J., Cao, L.-P., Lam, V., Mui, A., Huber, M. C., & Krystal, G. (2003) · Springer eBooks · doi:10.1007/s10254-003-0016-y · Cited by 101
Harder, K. W., Quilici, C., Naik, E., Inglese, M., Kountouri, N., Turner, A. L., Zlatic, K., Tarlinton, D. M., & Hibbs, M. L. (2004) · Blood · doi:10.1182/blood-2003-12-4396 · Cited by 99
Terzioglu, G., & Young-Pearse, T. L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00674-9 · Cited by 91
Kisseleva, M. V., Cao, L., & Majerus, P. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105969200 · Cited by 95
Activation of SHIP by NADPH Oxidase-stimulated Lyn Leads to Enhanced Apoptosis in Neutrophils
Gardai, S. J., Whitlock, B. B., Helgason, C. D., Ambruso, D., Fadok, V. A., Bratton, D. L., & Henson, P. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110005200 · Cited by 94
Nakamura, K., Malykhin, A., & Coggeshall, K. M. (2002) · Blood · doi:10.1182/blood-2002-03-0787 · Cited by 94
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
Mager, L. F., Riether, C., Schürch, C. M., Banz, Y., Wasmer, M.-H., Stuber, R., Theocharides, A. P. A., Li, X., Xia, Y., Saito, H., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77347 · Cited by 95
Dilek, N., de Silly, R. V., Blancho, G., & Vanhove, B. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00208 · Cited by 93
Gurung, R., Tan, A. W., Ooms, L. M., McGrath, M. J., Huysmans, R. D., Munday, A. D., Prescott, M., Whisstock, J. C., & Mitchell, C. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209991200 · Cited by 93
Choi, Y., Zhang, J., Murga, C., Yu, H., Koller, E., Monia, B. P., Gutkind, J. S., & Li, W. (2002) · Oncogene · doi:10.1038/sj.onc.1205650 · Cited by 93
Phosphoinositide Phosphatases: Just as Important as the Kinases
Dyson, J. M., Fedele, C. G., Davies, E. M., Becanovic, J., & Mitchell, C. A. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-3012-0_7 · Cited by 94
Targeting c-Kit mutations: basic science to novel therapies
Sattler, M., & Salgia, R. (2003) · Leukemia Research · doi:10.1016/j.leukres.2003.10.004 · Cited by 92
Portrait of PTEN: Messages from mutant mice
Suzuki, A., Nakano, T., Mak, T. W., & Sasaki, T. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00670.x · Cited by 92
Self-citationNabata, A., Kuroki, M., Ueba, H., Hashimoto, S., Umemoto, T., Wada, H., Yasu, T., Saito, M., Momomura, S., & Kawakami, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.003 · Cited by 88
SHIP1 and Lyn Kinase Negatively Regulate Integrin αIIbβ3 Signaling in Platelets
Maxwell, M. J., Yuan, Y., Anderson, K. E., Hibbs, M. L., Salem, H. H., & Jackson, S. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400746200 · Cited by 88
Tu, Z., Ninos, J. M., Ma, Z., Wang, J., Lemos, M. P., Desponts, C., Ghansah, T., Howson, J. M., & Kerr, W. G. (2001) · Blood · doi:10.1182/blood.v98.7.2028 · Cited by 82
Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5
Xiao, W., Hong, H., Kawakami, Y., Lowell, C. A., & Kawakami, T. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34013 · Cited by 82
Phosphoinositide phosphatases in a network of signalling reactions
Bléro, D., Payrastre, B., Schurmans, S., & Erneux, C. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0304-5 · Cited by 82
mTOR Complex 2 Targets Akt for Proteasomal Degradation via Phosphorylation at the Hydrophobic Motif
Wu, Y., Ouyang, W., Lazorchak, A. S., Liu, D., Shen, H., & Su, B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.219923 · Cited by 84
Vedham, V., Phee, H., & Coggeshall, K. M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4211-4220.2005 · Cited by 76
Inositol Polyphosphate Phosphatases in Human Disease
Hakim, S., Bertucci, M. C., Conduit, S. E., Vuong, D. L., & Mitchell, C. A. (2012) · Current topics in microbiology and immunology · doi:10.1007/978-94-007-5025-8_12 · Cited by 77
Mao, M., Fang, X., Lu, Y., LaPushin, R., Bast, R. C., & Mills, G. B. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3520475 · Cited by 76
Metadata
- Authors
- Liu, Q., Sasaki, T., Kozieradzki, I., Wakeham, A., Itie, A., Dumont, D. J., & Penninger, J. M.
- Affiliations
- University of Toronto (CA)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1999-04-01
- Volume
- 13
- Issue
- 7
- Pages
- 786-791
- ISSN
- 0890-9369 (ISSN-L)
- PMC
- PMC316591
- OpenAlex
- W2151313755
- Cited by
- 341
- References
- 31
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 7 · 2023: 12 · 2022: 5 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 10 · 2017: 8 · 2016: 9 · 2015: 7 · 2014: 10 · 2013: 14 · 2012: 17
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- ships, inositol polyphosphate 5-phosphatase, phosphatidylinositol 3-kinase, phosphatidylinositol 3,4,5-trisphosphate, Akt signaling, apoptosis, GM-CSF receptor, growth factor withdrawal, myeloid hyperplasia, splenomegaly, mast cells, neutrophils
- MeSH terms
- Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases, Animals, Anisomycin, Bone Marrow, Cell Line, Cell Survival, Cycloheximide, Enzyme Activation, Interleukin-3, Mice, Inbred C57BL, Neutrophils, Phosphoric Monoester Hydrolases, Precipitin Tests, Proto-Oncogene Proteins, Sorbitol, Spleen, Time Factors, Blotting, Southern, Blotting, Western, Down-Regulation, Apoptosis, Protein Serine-Threonine Kinases, Mice, Knockout, Proto-Oncogene Proteins c-akt, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review